Hyloris Pharmaceuticals Investor Relations Material
Latest events
Investor Presentation
29 Mar, 2025
H2 2024
20 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Hyloris Pharmaceuticals SA
Access all reports
Hyloris Pharmaceuticals SA is a Belgian specialty pharmaceutical company that develops reformulated and repurposed medicines. Its portfolio focuses on improving existing drugs to address unmet clinical needs across hospital and emergency care settings. The company engages in regulatory development and commercialization through partnerships. It is headquartered in Liège, Belgium, and its shares are listed on the EURONEXT Brussels.
Key slides for Hyloris Pharmaceuticals SA
Investor Presentation
Hyloris Pharmaceuticals SA
Investor Presentation
Hyloris Pharmaceuticals SA
Latest articles
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
Ticker symbol
HYL
Country
🇧🇪 Belgium